Capillary serum and plasma NfL concentrations between pre-HD and healthy controls replicated venous blood disease group differences, previously reported in the literature (Serum: Fig. 6F; Plasma: Supplementary Fig. 15a) [7, 8, 14, 30]. This evidence concerns the gene NEFL and Huntington disease.